EUVIMEDEUVIMED entdecken
Crossref

A robust HPLC-HILIC enrichment system for O-glycoproteomics profiling of plasma and cerebrospinal fluid across Alzheimer's disease progression

Zhenpeng Deng, Yan Wang, Lei Liu, Xin Guo, Haiyang Zhu, Mingming Dong, Yusong Ge, Yongliang Yu, Mingliang Ye

Analytica Chimica Acta · 2026-10 · 1419 · 345899

DOI: 10.1016/j.aca.2026.345899 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Analytica Chimica Acta, 2026-10. Verfasst von Zhenpeng Deng und 8 weiteren Autor:innen. Beteiligte Einrichtung: Research Center for Analytical Sciences, Department of Chemistry, College of Sciences, Northeastern University, Box 332, Shenyang, 110819, China; Sta…. Hauptthemen laut MEDLINE: Alzheimer Disease, Proteomics, Glycoproteins, Glycopeptides. Die Arbeit nennt 49 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND Alzheimer's disease (AD) pathogenesis involves widespread molecular alterations in both brain tissue and peripheral biofluids, yet the role of protein O-linked glycosylation in disease progression remains poorly characterized due to technical limitations in comprehensive O-glycoproteome profiling. RESULTS To address this gap, we developed a robust high-performance liquid chromatography-hydrophilic interaction chromatography (HPLC-HILIC) system optimized for efficient enrichment of intact O-glycopeptides from protein digests of complex biological matrices. This system was applied to characterize the O-glycoproteomes of plasma samples across different stages of AD progression, as well as those of cerebrospinal fluid (CSF) from AD patients. Notably, in plasma, it was found that fucosylated glycopeptides were down-regulated and sialylated glycopeptides were up-regulated as the disease progressed. In contrast, CSF samples exhibited an increased number of O-glycopeptides, accompanied by higher levels of sialylation. Furthermore, analysis of O-glycosylation patterns in AD CSF and plasma following blood-brain barrier disruption revealed increased O-glycosylation of ITIH4 (Q14624) and SERPINA5 (P05154) in plasma, and enhanced sialylated O-glycosylation of APOE (P02649) in CSF. These observations suggest that sialylated O- glycosylation may play a crucial role in the pathology of AD. SIGNIFICANCE Collectively, a robust O-glycoproteomic workflow was presented to investigate O-glycosylation patterns between CSF and plasma in AD. The results provide valuable insights into the involvement of O-glycosylation in AD progression and highlight the potential of this analytical platform for studying O-glycosylation dynamics in AD and other neurodegenerative disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseProteomicsGlycoproteinsGlycopeptidesHumansChromatography, High Pressure LiquidGlycosylationDisease ProgressionHydrophobic and Hydrophilic Interactions

Stichwörter der Autor:innen

Alzheimer's diseaseGlycopeptide enrichmentHydrophilic interaction chromatographyMucinsProtein O-GalNAcylation

Substanzen

GlycoproteinsGlycopeptides

Autor:innen und Institutionen

  • Research Center for Analytical Sciences, Department of Chemistry, College of Sciences, Northeastern University, Box 332, Shenyang, 110819, China; State Key Laboratory of Medical Proteomics, National Chromatographic R. &…
  • State Key Laboratory of Medical Proteomics, National Chromatographic R. & A. Center, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian, 116023, China; University of Chinese Academy of Sciences, B…
  • State Key Laboratory of Medical Proteomics, National Chromatographic R. & A. Center, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian, 116023, China; MOE Key Laboratory of Bio-Intelligent Manufa…
  • MOE Key Laboratory of Bio-Intelligent Manufacturing, School of Bioengineering, Dalian University of Technology, Dalian, Liaoning, 116000, China.
  • Department of Neurology, The Second Hospital of Dalian Medical University, Dalian, Liaoning, 116027, China. Electronic address: geyusongmed@dmu.edu.cn.
  • Research Center for Analytical Sciences, Department of Chemistry, College of Sciences, Northeastern University, Box 332, Shenyang, 110819, China. Electronic address: yuyl@mail.neu.edu.cn.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Deng, Z., Wang, Y., Liu, L., Guo, X., Zhu, H., Dong, M., Ge, Y., Yu, Y., & Ye, M. (2026). A robust HPLC-HILIC enrichment system for O-glycoproteomics profiling of plasma and cerebrospinal fluid across Alzheimer's disease progression. Analytica Chimica Acta, 1419, 345899. https://doi.org/10.1016/j.aca.2026.345899

Vancouver

Deng Z, Wang Y, Liu L, Guo X, Zhu H, Dong M, et al. A robust HPLC-HILIC enrichment system for O-glycoproteomics profiling of plasma and cerebrospinal fluid across Alzheimer's disease progression. Analytica Chimica Acta. 2026;1419:345899. doi:10.1016/j.aca.2026.345899

BibTeX
@article{Deng2026,
  author = {Deng, Zhenpeng and Wang, Yan and Liu, Lei and Guo, Xin and Zhu, Haiyang and Dong, Mingming and Ge, Yusong and Yu, Yongliang and Ye, Mingliang},
  title = {A robust HPLC-HILIC enrichment system for O-glycoproteomics profiling of plasma and cerebrospinal fluid across Alzheimer's disease progression},
  journal = {Analytica Chimica Acta},
  year = {2026},
  volume = {1419},
  pages = {345899},
  doi = {10.1016/j.aca.2026.345899}
}
Kostenlos starten →